Triple-Negative Breast Cancer: Updates on Research & Treatment
Virtual Event
CostFree
Description
Join us for an informative and empowering online session dedicated to triple‑negative breast cancer (TNBC)—a fast‑growing subtype of breast cancer that requires specialized care and up‑to‑date knowledge.
Led by experts from Atrium Health Levine Cancer, this event will cover the latest advancements in TNBC research, current treatment approaches, and supportive resources available to patients and families.
Attendees will also hear personal perspectives that highlight the strength and resilience of those affected by TNBC, fostering hope and connection within our community.
For breast cancer patients, care partners, and Atrium Health/Advocate Health teammates.
Please join us Wednesday, March 25 • 12:00–1:00 p.m. ET • Online (free) • This event will not be recorded.
Presenter:
Antoinette Tan, MD MHS
Chief, Breast Medical Oncology Section
Atrium Health Levine Cancer
Facilitator:
Department of Supportive Oncology (DSO), Atrium Health Levine Cancer Brought to you by the Sandra Levine Young Women’s Breast Cancer Program as part of The Mind‑Body‑Spirit Connection patient education series.
This session is educational and not a substitute for medical care. Please consult your care team for personal guidance.
For event or registration questions, email LCISupportiveOncology@advocatehealth.org.
Speakers
Antoinette Tan, MD, MHSc, FACP, FASCO
Dr. Antoinette R. Tan, MD, MHSc, FACP, FASCO, serves as the Chief of Breast Medical Oncology, Director of the Phase I Program, and Chair of the Department of Solid Tumor and Investigational Therapeutics at Atrium Health Levine Cancer Institute in Charlotte, North Carolina. She is Professor in the Department of Medicine, Section on Hematology and Oncology, at Wake Forest University School of Medicine.
Dr. Tan graduated from Rutgers University in 1993 with a bachelor’s degree in Biological Sciences. She earned her medical degree from Rutgers-Robert Wood Johnson Medical School in 1996 through an accelerated BA/MD program. Following her internship and residency in internal medicine at North Shore University Hospital–New York University School of Medicine and Memorial Sloan-Kettering Cancer Center, she completed an oncology fellowship at the National Cancer Institute. During her fellowship, Dr. Tan also received formal training in clinical research and was awarded a Master of Health Sciences degree from Duke University School of Medicine.
Her clinical research interests are centered on targeted treatments for triple-negative breast cancer and drug development. Dr. Tan has extensive experience in conducting early phase clinical trials as well as phase II and III breast cancer studies.